The emerging era of pharmacogenomics: current successes, future potential, and challenges

10.1111/cge.12392

Saved in:
Bibliographic Details
Main Authors: Lee, JW, Aminkeng, F, Bhavsar, AP, Shaw, K, Carleton, BC, Hayden, MR, Ross, CJD
Other Authors: MEDICINE
Format: Review
Language:English
Published: WILEY 2022
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/235301
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-235301
record_format dspace
spelling sg-nus-scholar.10635-2353012024-04-17T09:53:27Z The emerging era of pharmacogenomics: current successes, future potential, and challenges Lee, JW Aminkeng, F Bhavsar, AP Shaw, K Carleton, BC Hayden, MR Ross, CJD MEDICINE Science & Technology Life Sciences & Biomedicine Genetics & Heredity ADRs adverse drug reactions anthracycline carbamazepine cisplatin codeine pharmacogenomics warfarin ANTHRACYCLINE-INDUCED CARDIOTOXICITY IMPLEMENTATION CONSORTIUM GUIDELINES WARFARIN DOSE REQUIREMENT ADVERSE DRUG-REACTIONS GENETIC POLYMORPHISMS HEARING-LOSS CHILDREN CODEINE CYP2C9 CHILDHOOD 10.1111/cge.12392 CLINICAL GENETICS 86 1 21-28 2022-12-05T02:16:57Z 2022-12-05T02:16:57Z 2014-07-01 2022-11-30T18:57:37Z Review Lee, JW, Aminkeng, F, Bhavsar, AP, Shaw, K, Carleton, BC, Hayden, MR, Ross, CJD (2014-07-01). The emerging era of pharmacogenomics: current successes, future potential, and challenges. CLINICAL GENETICS 86 (1) : 21-28. ScholarBank@NUS Repository. https://doi.org/10.1111/cge.12392 0009-9163 1399-0004 https://scholarbank.nus.edu.sg/handle/10635/235301 en WILEY Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Genetics & Heredity
ADRs
adverse drug reactions
anthracycline
carbamazepine
cisplatin
codeine
pharmacogenomics
warfarin
ANTHRACYCLINE-INDUCED CARDIOTOXICITY
IMPLEMENTATION CONSORTIUM GUIDELINES
WARFARIN DOSE REQUIREMENT
ADVERSE DRUG-REACTIONS
GENETIC POLYMORPHISMS
HEARING-LOSS
CHILDREN
CODEINE
CYP2C9
CHILDHOOD
spellingShingle Science & Technology
Life Sciences & Biomedicine
Genetics & Heredity
ADRs
adverse drug reactions
anthracycline
carbamazepine
cisplatin
codeine
pharmacogenomics
warfarin
ANTHRACYCLINE-INDUCED CARDIOTOXICITY
IMPLEMENTATION CONSORTIUM GUIDELINES
WARFARIN DOSE REQUIREMENT
ADVERSE DRUG-REACTIONS
GENETIC POLYMORPHISMS
HEARING-LOSS
CHILDREN
CODEINE
CYP2C9
CHILDHOOD
Lee, JW
Aminkeng, F
Bhavsar, AP
Shaw, K
Carleton, BC
Hayden, MR
Ross, CJD
The emerging era of pharmacogenomics: current successes, future potential, and challenges
description 10.1111/cge.12392
author2 MEDICINE
author_facet MEDICINE
Lee, JW
Aminkeng, F
Bhavsar, AP
Shaw, K
Carleton, BC
Hayden, MR
Ross, CJD
format Review
author Lee, JW
Aminkeng, F
Bhavsar, AP
Shaw, K
Carleton, BC
Hayden, MR
Ross, CJD
author_sort Lee, JW
title The emerging era of pharmacogenomics: current successes, future potential, and challenges
title_short The emerging era of pharmacogenomics: current successes, future potential, and challenges
title_full The emerging era of pharmacogenomics: current successes, future potential, and challenges
title_fullStr The emerging era of pharmacogenomics: current successes, future potential, and challenges
title_full_unstemmed The emerging era of pharmacogenomics: current successes, future potential, and challenges
title_sort emerging era of pharmacogenomics: current successes, future potential, and challenges
publisher WILEY
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/235301
_version_ 1800915747184050176